- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
The 5 Cannabis Sectors Performed Quite Differently This Past Week
December 17, 2022
From TalkMarkets
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific
December 17, 2022
From TalkMarkets
Cannabis Category Performances Ranged From -5.1% To -35.3% Last Week
December 12, 2022
From TalkMarkets
Protalix BioTherapeutics Well Placed to Advance in 2023
December 12, 2022
From TalkMarkets
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
December 11, 2022
From TalkMarkets
From TalkMarkets
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
December 04, 2022
From TalkMarkets
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
December 03, 2022
From TalkMarkets
Biotech Space Offers Reward In 2023 Despite Economic Risks
November 30, 2022
From TalkMarkets
The Most Popular Stocks Millennial And Gen-Z Are Investing In
November 30, 2022
From TalkMarkets
Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead
November 28, 2022
From TalkMarkets
Market Currents: Why Pick Stocks?
November 28, 2022
From TalkMarkets
Cannabis Category Performances Last Week Ranged From +5.2% To -2.3%
November 27, 2022
From TalkMarkets
Psychedelic Drug Stocks Index Has A Good Week
November 27, 2022
From TalkMarkets
From TalkMarkets
Cannabis Category Performances Ranged From +2.6% To -5.8% Last Week
November 21, 2022
From TalkMarkets
Psychedelic Drug Stocks Index Continued To Decline Last Week
November 20, 2022
From TalkMarkets
The US Accounts For Nearly Half Of Global Diabetes Drug Sales
November 20, 2022
Tickers
LLY
From TalkMarkets
Tickers
MRNS
From TalkMarkets
Daily Stock Analysis: Sanofi - November 2022 Snapshot
November 16, 2022
From TalkMarkets
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
November 15, 2022
From TalkMarkets
From TalkMarkets
Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion
November 12, 2022
From TalkMarkets
A Comparison Of 5 Psychedelic ETFs And Indices
November 11, 2022
From TalkMarkets
Market Briefing For Wednesday, Nov. 9
November 09, 2022
From TalkMarkets
Curaleaf Q3 Report Reveals +80% Decrease In Net Profit
November 08, 2022
Tickers
CURLF
From TalkMarkets
Will Merck Continue Its Bullish Streak? A Wyckoff Analysis
November 08, 2022
Tickers
MRK
From TalkMarkets
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
November 07, 2022
From TalkMarkets
Risk Appetites Survive China Keeping Zero COVID Policy
November 07, 2022
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.